Onconetix Sets Second 1-for-10 Reverse Stock Split for Nov. 6

Onconetix, Inc. (Nasdaq: ONCO) plans another 1-for-10 reverse stock split of its outstanding common stock, bringing its aggregate split ratio to 1-for-100 when the change takes effect Nov. 6. Onconetix announced that its board approved the additional split. Under the new ratio, every 10 outstanding common shares will be combined into one. The company completed a separate 1-for-10 reverse stock split on May 21, 2026. The new split is expected to take effect at 12:01 a.m. ET Nov. 6. Split-adjusted trading is expected to begin at the market open that day. John Kim reports on the digital-asset business for TokenPost.

Source: TokenPost